Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

Silke Appel-Cresswell*, Carles Vilarino-Guell, Mary Encarnacion, Holly Sherman, Irene Yu, Brinda Shah, David Weir, Christina Thompson, Chelsea Szu-Tu, Joanne Trinh, Jan O. Aasly, Alex Rajput, Ali H. Rajput, A. Jon Stoessl, Matthew J. Farrer

*Corresponding author for this work
354 Citations (Scopus)


Background: Alpha-synuclein plays a central role in the pathophysiology of Parkinson's disease. Three missense mutations in SNCA, the gene encoding alpha-synuclein, as well as genomic multiplications have been identified as causes for autosomal-dominantly inherited Parkinsonism. Methods: Here, we describe a novel missense mutation in exon 4 of SNCA encoding a H50Q substitution in a patient with dopa-responsive Parkinson's disease with a family history of parkinsonism and dementia. Results: The variant was not observed in public databases or identified in unrelated subjects. Conclusions: The substitution's evolutionary conservation and protein modeling provide additional support for pathogenicity as the amino acid perturbs the same amphipathic alpha helical structure as the previously described pathogenic mutations.

Original languageEnglish
JournalMovement Disorders
Issue number6
Pages (from-to)811-813
Number of pages3
Publication statusPublished - 06.2013


Dive into the research topics of 'Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease'. Together they form a unique fingerprint.

Cite this